These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 84461)

  • 21. Detection and quantification of 8-methoxypsoralen-DNA adducts.
    Santella RM; Yang XY; DeLeo VA; Gasparro FP
    IARC Sci Publ; 1988; (89):333-40. PubMed ID: 3058601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between 8-methoxypsoralen and phenytoin. Consequence for PUVA therapy.
    Staberg B; Hueg B
    Acta Derm Venereol; 1985; 65(6):553-5. PubMed ID: 2420126
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Morphologic changes in epidermis of PUVA-treated patients with psoriasis with or without a history of arsenic therapy.
    Niemi KM; Niemi A; Kanerva L
    Arch Dermatol; 1983 Nov; 119(11):904-9. PubMed ID: 6639110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The history of photochemotherapy.
    Roelandts R
    Photodermatol Photoimmunol Photomed; 1991 Oct; 8(5):184-9. PubMed ID: 1822680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of PUVA on the epidermal melanocyte population in psoriatic patients.
    Rosdahl IK; Swanbeck G
    Acta Derm Venereol; 1980; 60(1):21-6. PubMed ID: 6153829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effectiveness of PUVA treatment in severe psoriasis is significantly increased by additional UV 308-nm excimer laser sessions.
    Trott J; Gerber W; Hammes S; Ockenfels HM
    Eur J Dermatol; 2008; 18(1):55-60. PubMed ID: 18086590
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of crude coal tar and topical methoxsalen in treatment of psoriasis.
    Petrozzi JW; Barton JO
    Arch Dermatol; 1979 Sep; 115(9):1061-3. PubMed ID: 485182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antinuclear antibodies during Puva therapy.
    Bjellerup M; Bruze M; Forsgren A; Krook G; Ljunggren B
    Acta Derm Venereol; 1979; 59(1):73-5. PubMed ID: 84474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial photochemotherapy of psoriasis with orally administered 8-methoxypsoralen and longwave ultraviolet light (PUVA).
    Siddiqui AH; Cormane RH
    Br J Dermatol; 1979 Mar; 100(3):247-50. PubMed ID: 435382
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Psoralen-UVA-treated psoriatic lesions. Ultrastructural changes.
    Hashimoto K; Kohda H; Kumakiri M; Blender SL; Willis I
    Arch Dermatol; 1978 May; 114(5):711-22. PubMed ID: 646392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-Methoxypsoralen (Bergapten) in photochemotherapy of psoriasis.
    Hönigsmann H; Jaschke E; Gschnait F; Brenner W; Fritsch P; Wolff K
    Br J Dermatol; 1979 Oct; 101(4):369-78. PubMed ID: 508604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experience with photochemotherapy with 8-methoxypsoralene by mouth and long-wave ultraviolet light (PUVA-treatment) in psoriasis].
    Suurmond D; Burger PM; Schothorst AA; Smit AF; van Vloten WA; Polano MK
    Ned Tijdschr Geneeskd; 1978 Jan; 122(3):69-75. PubMed ID: 622199
    [No Abstract]   [Full Text] [Related]  

  • 33. 8-MOP PUVA for psoriasis: a comparison of a minimal phototoxic dose-based regimen with a skin-type approach.
    Collins P; Wainwright NJ; Amorim I; Lakshmipathi T; Ferguson J
    Br J Dermatol; 1996 Aug; 135(2):248-54. PubMed ID: 8881668
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The importance of patient selection for photochemotherapy in psoriasis.
    DesGroseilliers JP; Reilly SM; Cullen AE
    Can Med Assoc J; 1981 Apr; 124(8):1016-8. PubMed ID: 7260785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experience.
    Pozo-Román T; González-López A; Velasco-Vaquero ME; Núñez-Cabezón M
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):136-42. PubMed ID: 16441619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bath PUVA and psoriasis: is a milder treatment a worse treatment?
    Delrosso G; Bornacina C; Farinelli P; Bellinzona F; Leigheb G; Colombo E
    Dermatology; 2008; 216(3):191-3. PubMed ID: 18182808
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Density of epidermal Langerhans cells in psoriasis patients treated with an aromatic retinoid (RO 10-9359). An immunoperoxidase study using anti-T6 and anti-Ia monoclonal antibodies.
    Guzman de Fleury M; Tapia FJ; Soto J; Ghersi N; Convit J
    Histol Histopathol; 1986 Jul; 1(3):227-34. PubMed ID: 2856536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 8-Methoxypsoralen-DNA adducts in patients treated with 8-methoxypsoralen and ultraviolet A light.
    Yang XY; Gasparro FP; DeLeo VA; Santella RM
    J Invest Dermatol; 1989 Jan; 92(1):59-63. PubMed ID: 2642513
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Double-blind studies on the effect of topical PUVA therapy for psoriasis. Supplement: open controlled studies on the effect of topical PUVA and topical steroid therapy for psoriasis. (author's transl)].
    Mizuno N
    Nihon Hifuka Gakkai Zasshi; 1980 Mar; 90(4):313-32. PubMed ID: 6991736
    [No Abstract]   [Full Text] [Related]  

  • 40. Evaluation of PUVA, topical corticosteroids and the combination of both in the treatment of psoriasis.
    Schmoll M; Henseler T; Christophers E
    Br J Dermatol; 1978 Dec; 99(6):693-702. PubMed ID: 737132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.